Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Feb 10;11(3):201-14.
doi: 10.1038/nrd3651.

Cancer biomarkers: selecting the right drug for the right patient

Gary J Kelloff  1 , Caroline C Sigman
Affiliations
Review

Cancer biomarkers: selecting the right drug for the right patient

Gary J Kelloff et al. Nat Rev Drug Discov. .

Abstract

This Perspective highlights biomarkers that are expressed as a consequence of cancer development and progression. We focus on those biomarkers that are most relevant for identifying patients who are likely to respond to a given therapy, as well as those biomarkers that are most effective for measuring patient response to therapy. These two measures are necessary for selecting the right drug for the right patient, regardless of whether the setting is in drug development or in the post-approval use of the drug for patients with cancer. We also discuss the innovative designs of clinical trials and methodologies that are used to validate and qualify biomarkers for use in specific contexts. Furthermore, we look ahead to the promises and challenges in the field of cancer biomarkers.

PubMed Disclaimer

References

    1. Cancer Res. 1992 Apr 1;52(7):1651-9 - PubMed
    1. Clin Cancer Res. 2011 Jul 15;17(14):4901-14 - PubMed
    1. Genet Med. 2009 Jan;11(1):3-14 - PubMed
    1. Cancer Discov. 2011 Jun;1(1):17-20 - PubMed
    1. BMC Genomics. 2006 Oct 30;7:278 - PubMed

LinkOut - more resources